166 related articles for article (PubMed ID: 38702603)
1. Life disturbance and hospital visit experiences among Chinese patients with benign prostatic hyperplasia: a qualitative study.
An Z; Zhou Q; Shao J; Xiao S; Zhao K; Wei W; Wu Y; Song Y; Yuan Q; Fu W; Zhang X
BMC Prim Care; 2024 May; 25(1):149. PubMed ID: 38702603
[TBL] [Abstract][Full Text] [Related]
2. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
Speakman M; Kirby R; Doyle S; Ioannou C
BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
[TBL] [Abstract][Full Text] [Related]
3. Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.
Ertel P; Adalig B; Demircan I; Lartey B; Manyak MJ
Int J Clin Pract; 2016 Oct; 70(10):870-880. PubMed ID: 27774780
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life and psychological well-being in patients with benign prostatic hyperplasia.
Pinto JD; He HG; Chan SW; Toh PC; Esuvaranathan K; Wang W
J Clin Nurs; 2015 Feb; 24(3-4):511-22. PubMed ID: 24850529
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
Xie Z; Liu X; Hu Z; Dong C
BMC Public Health; 2024 Apr; 24(1):1121. PubMed ID: 38654263
[TBL] [Abstract][Full Text] [Related]
6. The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Yang YJ; Koh JS; Ko HJ; Cho KJ; Kim JC; Lee SJ; Pae CU
J Korean Med Sci; 2014 Aug; 29(8):1145-51. PubMed ID: 25120327
[TBL] [Abstract][Full Text] [Related]
7. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
[TBL] [Abstract][Full Text] [Related]
8. Real-world data and treatment patterns of patients with lower urinary tract symptoms due to benign prostatic hyperplasia in Germany: an observational study using health insurance claims data.
Miernik A; Fritzsche J; Libutzki B; Malka V; Kilemnik I; Mohebbi D; May M; Gratzke C; Suarez-Ibarrola R
World J Urol; 2021 Dec; 39(12):4381-4388. PubMed ID: 34292368
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in middle-aged and older Chinese individuals: Results from the China Health and Retirement Longitudinal Study.
Zhang W; Cao G; Sun Y; Wu F; Wang Q; Xu T; Hu H; Xu K
J Affect Disord; 2022 Jan; 296():660-666. PubMed ID: 34565588
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study.
Zhang W; Zhang X; Li H; Wu F; Wang H; Zhao M; Hu H; Xu K
BMJ Open; 2019 Jun; 9(6):e022792. PubMed ID: 31221864
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
Kim HH; Kong KA; Lee HJ; Yoon H; Lee BE; Moon OR; Park H
J Prev Med Public Health; 2006 Mar; 39(2):141-8. PubMed ID: 16615269
[TBL] [Abstract][Full Text] [Related]
12. The association between personality traits and treatment outcomes in Korean patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a preliminary study.
Koh JS; Ko HJ; Cho KJ; Kim JC; Lee SJ; Pae CU
Gen Hosp Psychiatry; 2014; 36(5):545-8. PubMed ID: 24973126
[TBL] [Abstract][Full Text] [Related]
13. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
Chen W; Man S; Wang B; Kadeerhan G; Huang X
Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
[TBL] [Abstract][Full Text] [Related]
14. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
[TBL] [Abstract][Full Text] [Related]
15. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
16. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates.
Egan KB
Urol Clin North Am; 2016 Aug; 43(3):289-97. PubMed ID: 27476122
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
18. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.
Cindolo L; Pirozzi L; Fanizza C; Romero M; Tubaro A; Autorino R; De Nunzio C; Schips L
Eur Urol; 2015 Sep; 68(3):418-25. PubMed ID: 25465970
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: Study protocol for an assessor-blinded, randomized controlled clinical trial.
Kim HB; Kim YI; Jeon JH; Kim E; Kim JY; Kwon O; Choi YE; Yang C; Han CH
Medicine (Baltimore); 2020 Apr; 99(15):e19678. PubMed ID: 32282720
[TBL] [Abstract][Full Text] [Related]
20. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
